4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000099
President and CEO acquired 10,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brunn Carsten President and CEO | 2022-06-01 | Option exercise | +10,938 | 534,390 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Brunn Carsten President and CEO | 2022-06-01 | Option exercise · Restricted Stock Units | −10,938 | 21,875 | D: show line 2 in the form |
Loading xslF345X03/wf-form4_165428903107199.xml…